- Advertisement -
- Advertisement -
Section Overview
Focuses on zero dropout, a dedicated child protection law, POCSO fast-track courts, HPV vaccination statewide expansion, and child rights education in curriculum.
Summary Ratings
| Fiscal Pressure | Economic Benefit | Social Benefit | Implementation Risk |
| LOW | LOW | HIGH | LOW |
Proposal-by-Proposal Analysis
The table below provides fiscal cost estimates and impact ratings for the principal proposals in this section.
| Key Proposal | Fiscal Cost Estimate | Economic Benefit | Social Benefit |
| Zero Dropout Tamil Nadu target | Enhanced monitoring + interventions: ₹50–80 cr/yr incremental. High social return. | MEDIUM | HIGH |
| Child protection special law + child welfare Tamil Nadu | Legislative drafting + implementation: ₹10–20 cr. Annual enforcement: ₹30–50 cr. | LOW | HIGH |
| Additional POCSO courts | 10–15 additional courts × ₹2–3 cr setup = ₹20–45 cr. Annual running ₹15–20 cr. | LOW | HIGH |
| HPV vaccine extended to all 14-yr girls statewide (from 4 pilot districts) | Current pilot cost: ~₹50 cr/yr. Full statewide: ~₹150–180 cr/yr (5 crore girls, 2-dose regime at ₹1,500/dose, 80% coverage). | MEDIUM | HIGH |
| Child helpline 1098 upgraded to international standard | ₹15–25 cr one-time IT/infrastructure upgrade. | LOW | HIGH |
Analytical Notes
⚑ Analytical Note: The HPV vaccination expansion is the most consequential health investment in this section — it will eliminate cervical cancer (3rd most common cancer in Indian women) within a generation if sustained. WHO estimates ₹1 invested in HPV vaccination returns ₹14–26 in healthcare cost savings over 30 years. At ₹150–180 crore/year, this is exceptional value. Tamil Nadu would be the first major Indian state to achieve universal HPV coverage.
